Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:36 PM UTC
| NCT Number | NCT02474160 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 5,000 participants |
| Active Locations | 139 sites in the US |
| Sponsor | National Cancer Institute LAO |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT02474160 is currently recruiting participants. This clinical trial study for hematopoietic and lymphatic system neoplasm is actively seeking new participants at 139 locations across the United States. The study is sponsored by National Cancer Institute LAO. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02474160 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 139 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02474160 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.